Wikidata

(Q63338611)

English

Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Randomized Double Blind Placebo Controlled Trial of Intranasal Submucosal Bevacizumab in Hereditary Hemorrhagic Telangiectasia (English)
0 references
country
Austria
0 references
start time
March 2011
0 references
end time
June 2013
0 references
number of participants
15
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63338611&oldid=2234458365"